Bringing the fundamentals into focus…
Back to BrainsWay Ltd.
How BrainsWay Ltd. stacks up
BWAY · against 433 other Healthcare companies of similar size
Valuation
41/ 100
Below the middle of the pack.
Ranked #224 of 434 · scores higher than 48% of peers
Bars: peers in each 10-point band of the valuation score36 peers with a valuation score of 40–49, including BWAY · Click a bar to see the companies
Why valuation scores 41?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- less operating profit (EBITDA) for the company's total value: weaker than 61% of peers. EBITDA yield: 2.2% vs peer median 4.0%
- Earnings yield is close to the peer norm. Earnings yield: 0.8% vs peer median 1.5%
- Free cash flow yield is close to the peer norm. Free cash flow yield: 1.3% vs peer median 0.0%
Metric by metric
Position: dot = BWAY, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BWAY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 420 reported | 2.1% | 0.3% | 63% | 30% | |
| EBITDA yieldHigher is better · 439 reported | 2.2% | 3.0% | 47% | 50% | |
| Free cash flow yieldHigher is better · 200 reported | 1.3% | -7.7% | 73% | 20% | |
| Book yieldHigher is better · 430 reported | 17.7% | 49.2% | 16% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around BWAYScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score